Analysis of Prognostic and Survival Factors Related to Treatment of Low-Grade Astrocytomas in Adults
暂无分享,去创建一个
Mitsutoshi Nakamura | H. Nakase | S. Tsunoda | N. Konishi | T. Sakaki | T. Tsuzuki | H. Aoki | H. Sakitani | T. Inui | Hiroyuki Nakase | Toshisuke Sakaki | Mitsutoshi Nakamura | Noboru Konishi | Shigeru Tsunoda | Toshihide Tsuzuki | Hideo Aoki | Hiroyuki Sakitani | Takuo Inui
[1] D. Louis,et al. Use of MIB‐1 (Ki‐67) Immunoreactivity in Differentiating Grade II and Grade III Gliomas , 1996, Journal of neuropathology and experimental neurology.
[2] W. Shapiro. Treatment of neuroectodermal brain tumors , 1982, Annals of neurology.
[3] P. Workman. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo? , 1995, Human & experimental toxicology.
[4] Mitsutoshi Nakamura,et al. p53‐independent WAF1 induction by ACNU in human glioblastoma cells , 1996, Molecular carcinogenesis.
[5] K. Skullerud,et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Piantadosi,et al. Low‐grade cerebral astrocytomas: Survival and quality of life after radiation therapy , 1990, Cancer.
[7] Y. Shibamoto,et al. Supratentorial low‐grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables , 1993, Cancer.
[8] C. Daumas-Duport,et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. , 1989, Journal of neurosurgery.
[9] J. Bruner,et al. Correlation of p53 immunoreactivity and sequencing in patients with glioma , 1996, Molecular carcinogenesis.
[10] C. Compton,et al. Proliferating cell nuclear antigen and mitotic activity in rectal cancer: predictor of response to preoperative irradiation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[12] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[13] D. Brachman,et al. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. , 1993, Cancer research.
[14] R. Miralbell,et al. Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] B. Scheithauer,et al. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients , 1993, Cancer.
[16] J. Delattre,et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. , 1996, International journal of radiation oncology, biology, physics.
[17] Douglas C. Miller,et al. Treatment and survival of low-grade astrocytoma in adults--1977-1988. , 1992, Neurosurgery.
[18] H. Thaler,et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas , 1988, Neurology.
[19] D. Housman,et al. p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.
[20] S. Tsunoda,et al. Immunohistochemical detection of CDKN2, retinoblastoma and p53 gene products in primary astrocytic tumors. , 1996, International journal of oncology.
[21] M. Mikhael,et al. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. , 1987, Neurosurgery.
[22] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[23] B. Fisher,et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Faist,et al. Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas , 1997, Cancer.
[25] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[26] T. Mikkelsen,et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.
[27] A. Chiò,et al. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. , 1989, Neurosurgery.
[28] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.
[29] S. Tsunoda,et al. Retinoblastoma protein expression and MIB‐1 correlate with survival of patients with malignant astrocytoma , 1997, Cancer.
[30] R. Makuch,et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. , 1996, Neurosurgery.
[31] G. Demers,et al. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. , 1996, Cancer research.
[32] K. Fulling,et al. The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum , 1985, Cancer.
[33] Johannes Gerdes,et al. Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.
[34] P. Warnke,et al. Low grade supratentorial astrocytomas: Management and prognostic factors , 1994, Cancer.
[35] J. M. Lee,et al. p53 mutations increase resistance to ionizing radiation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Tsunoda,et al. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas , 1996, Cancer.
[37] D. Kondziolka,et al. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.
[38] B. Scheithauer,et al. Histological Classification of Tumours of the Central Nervous System , 1993 .
[39] M. Prados,et al. Gemistocytic astrocytomas: a reappraisal. , 1991, Journal of neurosurgery.